Neotropix's Series B Round

Neotropix raised a round of funding on September 12, 2008.

Neotropix 1 is a virotherapy company, dedicated to the development and commercialization of virus-based therapies for the treatment of cancer and other diseases. Per Neotropix, virotherapy holds grea…

Articles about Neotropix's Series B Round: